A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06425991 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06425991
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2025-06-03
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.